Literature DB >> 15856034

An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al.

P-H Zahl.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15856034      PMCID: PMC2362031          DOI: 10.1038/sj.bjc.6602581

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Sir, In a recent paper, Bucchi report that the risk of axillary lymph node metastases for screening detected cancers is increasing more rapidly than for clinically detected cancers even after adjusting for other risk factors. They argue that overdiagnosis may not explain their results. I believe that overdiagnosis actually may explain their results. Further, Bucchi et al claim there is ‘no published data support on an inverse association between overdiagnosis and tumour size’. Actually, there are a lot of recent papers on the association between mammography screening and overdiagnosis of small tumours (Olsen and Gotzsche, 2001); (Zahl ). Most recently, Joensuu reported an extremely high level of length time bias in screening detected cancers in the Finnish mammography screening programme.
  4 in total

1.  Cochrane review on screening for breast cancer with mammography.

Authors:  O Olsen; P C Gøtzsche
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Risk for distant recurrence of breast cancer detected by mammography screening or other methods.

Authors:  Heikki Joensuu; Tiina Lehtimäki; Kaija Holli; Liisa Elomaa; Taina Turpeenniemi-Hujanen; Vesa Kataja; Ahti Anttila; Mikael Lundin; Jorma Isola; Johan Lundin
Journal:  JAMA       Date:  2004-09-01       Impact factor: 56.272

3.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

Authors:  Per-Henrik Zahl; Bjørn Heine Strand; Jan Maehlen
Journal:  BMJ       Date:  2004-03-10

4.  Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.

Authors:  L Bucchi; A Barchielli; A Ravaioli; M Federico; V De Lisi; S Ferretti; E Paci; M Vettorazzi; S Patriarca; A Frigerio; E Buiatti
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.